Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Magenta Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing novel medicines to extend the curative power of stem cell transplant, gene therapy, genome editing, and cell therapy. The pipeline of the company includes MGTA-117, MGTA-145, and others.
| Last: | $55.93 |
|---|---|
| Change Percent: | 7.56% |
| Open: | $53.15 |
| Close: | $52 |
| High: | $56.77 |
| Low: | $52.465 |
| Volume: | 406,883 |
| Last Trade Date Time: | 02/27/2026 12:40:49 pm |
| Market Cap: | $2,196,597,434 |
|---|---|
| Float: | 37,892,819 |
| Insiders Ownership: | 0.47% |
| Institutions: | 33 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.dianthustx.com |
| Country: | US |
| City: | New York |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Dianthus Therapeutics Inc. (NASDAQ: DNTH).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
